AstraZeneca, Russia to launch joint trial of COVID-19 vaccines before end of year

AstraZeneca said Dec. 11 that it will begin a clinical trial of its COVID-19 vaccine in combination with Russia’s COVID-19 vaccine before the end of the year. 

Advertisement

The trial will enroll volunteers 18 years and older. 

Preliminary results have shown Russia’s Sputnik V vaccine to be 90 percent effective in preventing COVID-19 infection, according to The Hill. Russia authorized the vaccine in August, the first country to do so. It began vaccinating people this week. 

Read AstraZeneca’s full news release here. 

More articles on pharmacy:
CVS targets customers in recruiting blitz ahead of COVID-19 vaccine approval
Stamford Health’s infectious diseases chair discusses health system’s COVID-19 vaccine plans
J&J cuts COVID-19 vaccine trial size due to spike in cases

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.